glp 1 or glp 2 A unique hormonal recognition feature of the human glucagon-like peptide-2 receptor Glucagon-like peptide (GLP)-2 axis. Glucagon-like

Important Considerations Regulatory status: AOD-9604 is not FDA-approved

Dzieyc, K., Litwin, T., Chabik, G., Gramza, K

Open Access This article has been published open access under our Subscribe to Open programme, made possible through the support of our subscribing institutions, learn more here: CRediT Author Contribution L.D.: Writing-originaldraft, funding acquisition, writingreview and editing, data curation, investigation

Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]